Every open market buy and sale of Regeneron Pharmaceuticals, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $65.2M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when REGN insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an REGN officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every REGN insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | George L SingDirector | Sale | 2,000 | $958.97 | $1.9M | 23,147 | Nov 18Form 4 |
| Nov 17, 2026 | Andrew J MurphyCo-Chief Scientific Officer | Sale plan | 5,011 | $957.76 | $4.8M | 46,779 | Nov 18Form 4 |
| Nov 16, 2026 | Marion McCourtEVP Commercial | Sale plan | 566 | $960.25 | $544K | 10,305 | Nov 18Form 4 |
| Nov 4, 2026 | Jason PitofskySVP Controller | Sale | 4,062 | $942.19 | $3.8M | 0 | Nov 6Form 4 |
| Nov 3, 2026 | Huda Y ZoghbiDirector | Sale | 7,439 | $970.46 | $7.2M | 1,703 | Nov 5Form 4 |
| Nov 2, 2026 | Christine A PoonDirector | Sale | 7,830 | $969.09 | $7.6M | 5,219 | Nov 4Form 4 |
| Nov 2, 2026 | George L SingDirector | Sale | 21,129 | $964.38 | $20.4M | 25,147 | Nov 4Form 4 |
| Nov 2, 2026 | Joseph J LarosaEVP General Counsel and Secret | Sale | 4,466 | $965.49 | $4.3M | 38,906 | Nov 4Form 4 |
| Oct 30, 2026 | Michael S BrownDirector | Sale plan | 1,929 | $875.00 | $1.7M | 1,380 | Nov 3Form 4 |
| Oct 30, 2026 | Marion McCourtEVP Commercial | Sale plan | 1,132 | $869.43 | $984K | 10,871 | Nov 3Form 4 |
| Oct 30, 2026 | Kathryn GuariniDirector | Sale plan | 400 | $900.00 | $360K | 603 | Nov 3Form 4 |
| Oct 14, 2026 | Andrew J MurphyCo-Chief Scientific Officer | Sale plan | 4,147 | $772.70 | $3.2M | 47,833 | Oct 15Form 4 |
| Sep 3, 2026 | Marion McCourtEVP Commercial | Sale plan | 2,346 | $853.56 | $2M | 12,003 | Sep 3Form 4 |
| Sep 2, 2026 | Kathryn GuariniDirector | Sale plan | 400 | $850.00 | $340K | 603 | Sep 3Form 4 |
| Aug 10, 2026 | Huda Y ZoghbiDirector | Sale plan | 800 | $800.00 | $640K | 1,703 | Aug 12Form 4 |
REGN insider trading FAQ
Are REGN insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of REGN on the open market in 0 trades, and 11 sold $65.2M in 25 trades, 31% of that under pre-arranged trading plans.
When did an REGN insider last buy shares?
There has been no open market insider purchase of REGN in the last two years.
When did an REGN insider last sell shares?
George L Sing (Director) sold 2,000 shares for $1.9M on Nov 17, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
